Should I buy or sell DocGo stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for DocGo in the last twelve months. There are currently 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" DCGO shares. View DCGO analyst ratings or view top-rated stocks .

What is DocGo's stock price target for 2024?

5 brokers have issued 1-year target prices for DocGo's shares. Their DCGO share price targets range from $8.00 to $16.00. On average, they anticipate the company's share price to reach $10.83 in the next twelve months. This suggests a possible upside of 233.3% from the stock's current price. View analysts price targets for DCGO or view top-rated stocks among Wall Street analysts .

How have DCGO shares performed in 2024?

DocGo's stock was trading at $5.59 at the start of the year. Since then, DCGO stock has decreased by 41.9% and is now trading at $3.25. View the best growth stocks for 2024 here .

Are investors shorting DocGo?

DocGo saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 10,490,000 shares, an increase of 5.9% from the March 15th total of 9,910,000 shares. Based on an average trading volume of 1,600,000 shares, the short-interest ratio is currently 6.6 days. Currently, 12.1% of the company's shares are short sold. View DocGo's Short Interest .

When is DocGo's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024. View our DCGO earnings forecast .

How were DocGo's earnings last quarter?

DocGo Inc. (NASDAQ:DCGO) posted its quarterly earnings data on Wednesday, February, 28th. The company reported $0.06 EPS for the quarter, missing analysts' consensus estimates of $0.13 by $0.07. The company earned $199.25 million during the quarter, compared to analysts' expectations of $195.48 million. DocGo had a trailing twelve-month return on equity of 2.01% and a net margin of 1.10%.

What ETFs hold DocGo's stock?

ETFs with the largest weight of DocGo (NASDAQ:DCGO) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC) . iShares U.S. Healthcare Providers ETF (IHF) .

What guidance has DocGo issued on next quarter's earnings?

DocGo updated its FY 2024 earnings guidance on Thursday, February, 29th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $720.0 million-$750.0 million, compared to the consensus revenue estimate of $753.9 million.

How do I buy shares of DocGo?

Shares of DCGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

Most-Downgraded StocksMost-Downgraded

NASDAQ:DCGO

DocGo (DCGO) Stock Price, News & Analysis

→ Elon Musk’s ChatGPT Could Soon Mint New Millionaires (From InvestorPlace) (Ad)

Free DCGO Stock Alerts

$3.25

-0.01 (-0.31%)

(As of 04/15/2024 ET)

Compare

Today's Range: $3.17
▼
$3.27
50-Day Range: $3.25
▼
$4.13
52-Week Range: $2.78
▼
$10.82

Volume: 1.07 million shs
Average Volume: 1.59 million shs
Market Capitalization: $338.55 million

P/E Ratio: 46.43
Dividend Yield: N/A
Price Target: $10.83

Get DocGo alerts:

DocGo MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 233.3% Upside
$10.83 Price Target
Short Interest: Bearish
12.14% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: -0.13
Based on 26 Articles This Week
Insider Trading: Acquiring Shares
$36,100 Bought Last Quarter
Proj. Earnings Growth: 25.71%
From $0.35 to $0.44 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.52 out of 5 stars

Medical Sector

93rd out of 929 stocks

Health Services Industry

2nd out of 10 stocks

4.5

Analyst's Opinion

Consensus Rating
DocGo has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
DocGo has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

1.0

Short Interest

Percentage of Shares Shorted
12.14% of the float of DocGo has been sold short.
Short Interest Ratio / Days to Cover
DocGo has a short interest ratio ("days to cover") of 6.6.
Change versus previous month
Short interest in DocGo has recently increased by 5.85%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
DocGo does not currently pay a dividend.
Dividend Growth
DocGo does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for DCGO.

1.6

News and Social Media Coverage

News Sentiment
DocGo has a news sentiment score of -0.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 26 news articles for DocGo this week, compared to 4 articles on an average week.
Search Interest
Only 2 people have searched for DCGO on MarketBeat in the last 30 days. This is a decrease of -60% compared to the previous 30 days.
MarketBeat Follows
13 people have added DocGo to their MarketBeat watchlist in the last 30 days. This is an increase of 86% compared to the previous 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, DocGo insiders have bought more of their company's stock than they have sold. Specifically, they have bought $36,100.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
13.78% of the stock of DocGo is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
56.44% of the stock of DocGo is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

4.4

Earnings and Valuation

Earnings Growth
Earnings for DocGo are expected to grow by 25.71% in the coming year, from $0.35 to $0.44 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of DocGo is 46.43, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 142.24.
Price to Earnings Ratio vs. Sector
The P/E ratio of DocGo is 46.43, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 249.13.
Price to Earnings Growth Ratio
DocGo has a PEG Ratio of 0.33. PEG Ratios below 1 indicate that a company could be undervalued.
Price to Book Value per Share Ratio
DocGo has a P/B Ratio of 1.11. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad InvestorPlace

Forget Nvidia, buy this A.I. Stock Now

Forget Nvidia, Microsoft or Google. Our tech expert and venture capitalist Luke Lango believes this is Elon Musk’s favorite A.I. stock. Why? Because this company is supplying Elon Musk with a key piece of advanced tech for his new A.I. venture.

Click here to see the details.

About DocGo Stock (NASDAQ:DCGO)

DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.

DCGO Stock Price History

30 days | 90 days | 365 days | Advanced Chart

DCGO Stock News Headlines

April 13, 2024 | americanbankingnews.com

Canaccord Genuity Group Lowers DocGo (NASDAQ:DCGO) Price Target to $9.00

April 13, 2024 | americanbankingnews.com

Q2 2024 Earnings Estimate for DocGo Inc. Issued By Northland Capmk (NASDAQ:DCGO)

April 16, 2024 | InvestorPlace (Ad)

Forget Nvidia, buy this A.I. Stock Now

April 12, 2024 | investing.com

Stifel cuts DocGo stock target, maintains buy amid contract shift

April 12, 2024 | americanbankingnews.com

FY2024 Earnings Estimate for DocGo Inc. Issued By Northland Capmk (NASDAQ:DCGO)

April 11, 2024 | markets.businessinsider.com

Peeling Back The Layers: Exploring DocGo Through Analyst Insights

April 11, 2024 | americanbankingnews.com

BTIG Research Trims DocGo (NASDAQ:DCGO) Target Price to $11.00

April 11, 2024 | americanbankingnews.com

DocGo (NASDAQ:DCGO) PT Lowered to $8.00

April 16, 2024 | InvestorPlace (Ad)

Forget Nvidia, buy this A.I. Stock Now

April 10, 2024 | businesswire.com

DocGo Signs Extension and Begins Planned Transition of Asylum Seeker Contract with New York City HPD

April 10, 2024 | msn.com

DocGo slips as New York City moves to end migrant contract

April 2, 2024 | businesswire.com

DocGo Becomes Official Partner of New York City Football Club

March 29, 2024 | businesswire.com

DOCGO INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of DocGo Inc. - DCGO

March 28, 2024 | finance.yahoo.com

Declining Stock and Decent Financials: Is The Market Wrong About DocGo Inc. (NASDAQ:DCGO)?

March 20, 2024 | markets.businessinsider.com

DocGo Inc. (DCGO) Investor Alert: Grabar Law Office Investigates Claims on Behalf Of DocGo Investors

March 20, 2024 | investing.com

DocGo CFO Norman Rosenberg buys $36.1k in company shares

March 20, 2024 | seekingalpha.com

DocGo: Upside Remains Attractive After Share Price Decline

March 20, 2024 | businesswire.com

DocGo Leadership Purchase Shares in Open Market

March 14, 2024 | nz.finance.yahoo.com

Tyler Perry’s Sistas Sets Season 7 Return Date Ahead of Midseason Finale — Watch Exclusive Trailer

March 14, 2024 | businesswire.com

DocGo Announces Repurchases of Common Stock and Adoption of 10b5-1 Trading Plan for Share Repurchase Program

March 1, 2024 | finance.yahoo.com

DocGo Full Year 2023 Earnings: EPS Misses Expectations

February 29, 2024 | markets.businessinsider.com

Expert Outlook: DocGo Through The Eyes Of 4 Analysts

February 29, 2024 | markets.businessinsider.com

Buy Rating Affirmed for DocGo: Strong FY23 Finish and Promising FY24 Outlook Fuel Growth Prospects

February 29, 2024 | insidermonkey.com

DocGo Inc. (NASDAQ:DCGO) Q4 2023 Earnings Call Transcript

February 28, 2024 | benzinga.com

Recap: DocGo Q4 Earnings

February 28, 2024 | msn.com

DocGo GAAP EPS of $0.06, revenue of $199.2M

February 28, 2024 | finance.yahoo.com

DocGo Announces Record Fourth Quarter and Full-Year 2023 Results

See More Headlines

Receive DCGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DocGo and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/28/2024
Today: 4/15/2024
Next Earnings (Estimated): 5/13/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Health services
Sub-Industry: N/A
Current Symbol: NASDAQ:DCGO
CUSIP: N/A
CIK: 1822359
Web: www.docgo.com
Phone: 844-443-6246
Fax: N/A
Employees: 4,164
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $10.83
High Stock Price Target: $16.00
Low Stock Price Target: $8.00
Potential Upside/Downside: +233.3%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 5 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.07
Trailing P/E Ratio: 46.43
Forward P/E Ratio: 9.29
P/E Growth: 0.33
Net Income: $6.86 million
Net Margins: 1.10%
Pretax Margin: 2.61%
Return on Equity: 2.01%
Return on Assets: 1.37%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.99
Quick Ratio: 1.99

Sales & Book Value

Annual Sales: $624.29 million
Price / Sales: 0.54
Cash Flow: $0.21 per share
Price / Cash Flow: 15.31
Book Value: $2.93 per share
Price / Book: 1.11

Miscellaneous

Outstanding Shares: 104,170,000
Free Float: 89,816,000
Market Cap: $338.55 million
Optionable: Optionable
Beta: 0.91

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

Mr. Lee Bienstock (Age 39)
CEO & Director
Comp: $1.24M
Mr. Ely D. Tendler (Age 56)
General Counsel, Secretary & Director
Mr. Norman Rosenberg (Age 54)
Treasurer & CFO
Mike Cole
Vice President of Investor Relations
Mr. Stephen Sugrue (Age 52)
Chief Compliance Officer
Mr. Ben Sherman
EVP of Corporate Development
Ms. Rosemarie Milano
Vice President of Human Resources
Mr. Andre Oberholzer CPA (Age 66)
Executive Vice President of Strategy
Comp: $1.75M
Mr. Aaron Severs
Chief Product Officer
Ms. Vrenely Munoz
Chief Revenue Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

DCGO Stock Analysis - Frequently Asked Questions

Should I buy or sell DocGo stock right now?: 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for DocGo in the last twelve months. There are currently 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" DCGO shares.
View DCGO analyst ratings or view top-rated stocks.
What is DocGo's stock price target for 2024?: 5 brokers have issued 1-year target prices for DocGo's shares. Their DCGO share price targets range from $8.00 to $16.00. On average, they anticipate the company's share price to reach $10.83 in the next twelve months. This suggests a possible upside of 233.3% from the stock's current price.
View analysts price targets for DCGO or view top-rated stocks among Wall Street analysts.
How have DCGO shares performed in 2024?: DocGo's stock was trading at $5.59 at the start of the year. Since then, DCGO stock has decreased by 41.9% and is now trading at $3.25.
View the best growth stocks for 2024 here.
Are investors shorting DocGo?: DocGo saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 10,490,000 shares, an increase of 5.9% from the March 15th total of 9,910,000 shares. Based on an average trading volume of 1,600,000 shares, the short-interest ratio is currently 6.6 days. Currently, 12.1% of the company's shares are short sold.
View DocGo's Short Interest.
When is DocGo's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024.
View our DCGO earnings forecast.

How were DocGo's earnings last quarter?: DocGo Inc. (NASDAQ:DCGO) posted its quarterly earnings data on Wednesday, February, 28th. The company reported $0.06 EPS for the quarter, missing analysts' consensus estimates of $0.13 by $0.07. The company earned $199.25 million during the quarter, compared to analysts' expectations of $195.48 million. DocGo had a trailing twelve-month return on equity of 2.01% and a net margin of 1.10%.
What ETFs hold DocGo's stock?: ETFs with the largest weight of DocGo (NASDAQ:DCGO) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC).iShares U.S. Healthcare Providers ETF (IHF).
What guidance has DocGo issued on next quarter's earnings?: DocGo updated its FY 2024 earnings guidance on Thursday, February, 29th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $720.0 million-$750.0 million, compared to the consensus revenue estimate of $753.9 million.
How do I buy shares of DocGo?: Shares of DCGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:DCGO) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

DocGo (DCGO) Stock Price, News & Analysis

DocGo MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About DocGo Stock (NASDAQ:DCGO)

DCGO Stock Price History

DCGO Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

DCGO Stock Analysis - Frequently Asked Questions

Overall MarketRank^™